Susquehanna Fundamental Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$4.74M Buy
+60,281
New +$4.94M 0.11% 240
2022
Q1
$965K Buy
+8,700
New +$919K 0.02% 852
2021
Q4
Sell
-119,871
Closed -$15M 1639
2021
Q3
$15M Sell
119,871
-43,566
-27% -$5.64M 0.28% 81
2021
Q2
$20.3M Hold
163,437
0.37% 43
2021
Q1
$19.3M Sell
163,437
-27,542
-14% -$3.23M 0.33% 52
2020
Q4
$22.4M Buy
190,979
+130,304
+215% +$14.3M 0.41% 14
2020
Q3
$6.3M Buy
+60,675
New +$6.09M 0.19% 134
2020
Q2
Sell
-56,000
Closed -$5.05M 986
2020
Q1
$5.05M Sell
56,000
-54,400
-49% -$5.79M 1.01% 26
2019
Q4
$12.5M Hold
110,400
1.64% 7
2019
Q3
$12M Hold
110,400
1.46% 7
2019
Q2
$10.8M Buy
110,400
+42,000
+61% +$3.83M 1.25% 9
2019
Q1
$6.23M Buy
68,400
+54,400
+389% +$4.87M 0.71% 38
2018
Q4
$1.27M Buy
+14,000
New +$1.31M 0.22% 135

Other funds holding MDT

Susquehanna Fundamental Investments's MDT Position: Q2 2024 in Review

Susquehanna Fundamental Investments opened a new position in Medtronic (MDT) in Q2 2024: 60,281 shares worth $4.74M. The stake represents 0.11% of the portfolio and ranks #240 among its holdings. This is a return to the name: Susquehanna Fundamental Investments previously reported a position in MDT as recently as Q1 2022.

Susquehanna Fundamental Investments first reported a position in MDT in Q4 2018 and has held it in 13 quarters since. The position peaked at $22.4M in Q4 2020. 2,024 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Susquehanna Fundamental Investments held 60,281 shares of Medtronic worth $4.74M as of Q2 2024.
  • Medtronic was a new Susquehanna Fundamental Investments position in Q2 2024.
  • Medtronic made up 0.11% of Susquehanna Fundamental Investments's portfolio in Q2 2024, its #240 holding.
  • Susquehanna Fundamental Investments first reported a position in Medtronic in Q4 2018 and has held it in 13 quarters since.
  • Susquehanna Fundamental Investments's Medtronic position peaked at $22.4M in Q4 2020.
  • 2,024 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.